After Eli Lilly's diet pills performed disappointing in a key trial, the company's CEO David Ricks and other insiders collectively bought nearly $3 million worth of shares in the subsequent stock sell-off. Eli Lilly's CEO David Ricks bought $1 million worth of the company's shares on Tuesday. After Lilly's diet pill trial data was disappointing and caused the stock price to plummet, several Eli Lilly executives and board members saw a buying opportunity. According to documents submitted to the US Securities and Exchange Commission, five Eli Lilly insiders have bought a total of $2.9 million worth of shares in recent days. These insiders include Eli Lilly's CEO David Ricks, who bought just over $1 million in shares on Tuesday.

Zhitongcaijing · 08/12/2025 23:25
After Eli Lilly's diet pills performed disappointing in a key trial, the company's CEO David Ricks and other insiders collectively bought nearly $3 million worth of shares in the subsequent stock sell-off. Eli Lilly's CEO David Ricks bought $1 million worth of the company's shares on Tuesday. After Lilly's diet pill trial data was disappointing and caused the stock price to plummet, several Eli Lilly executives and board members saw a buying opportunity. According to documents submitted to the US Securities and Exchange Commission, five Eli Lilly insiders have bought a total of $2.9 million worth of shares in recent days. These insiders include Eli Lilly's CEO David Ricks, who bought just over $1 million in shares on Tuesday.